Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP925124.RA5DOqe0CqxtOpVX-kTRLxpZ1OhkO3miaE4JErmqx2oiY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925124.RA5DOqe0CqxtOpVX-kTRLxpZ1OhkO3miaE4JErmqx2oiY130_assertion type Assertion NP925124.RA5DOqe0CqxtOpVX-kTRLxpZ1OhkO3miaE4JErmqx2oiY130_head.
- NP925124.RA5DOqe0CqxtOpVX-kTRLxpZ1OhkO3miaE4JErmqx2oiY130_assertion description "[Clinical, virological, histological characteristics, and biochemical tests including; liver function tests (ALT and AST), prothrombin time (PT), alpha fetoprotein (AFP), complete blood picture (CBC), and hGH were monitored in hepatitis C genotype-4 infected patients before and after interferon therapy, and healthy controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925124.RA5DOqe0CqxtOpVX-kTRLxpZ1OhkO3miaE4JErmqx2oiY130_provenance.
- NP925124.RA5DOqe0CqxtOpVX-kTRLxpZ1OhkO3miaE4JErmqx2oiY130_assertion evidence source_evidence_literature NP925124.RA5DOqe0CqxtOpVX-kTRLxpZ1OhkO3miaE4JErmqx2oiY130_provenance.
- NP925124.RA5DOqe0CqxtOpVX-kTRLxpZ1OhkO3miaE4JErmqx2oiY130_assertion SIO_000772 21933670 NP925124.RA5DOqe0CqxtOpVX-kTRLxpZ1OhkO3miaE4JErmqx2oiY130_provenance.
- NP925124.RA5DOqe0CqxtOpVX-kTRLxpZ1OhkO3miaE4JErmqx2oiY130_assertion wasDerivedFrom befree-2016 NP925124.RA5DOqe0CqxtOpVX-kTRLxpZ1OhkO3miaE4JErmqx2oiY130_provenance.
- NP925124.RA5DOqe0CqxtOpVX-kTRLxpZ1OhkO3miaE4JErmqx2oiY130_assertion wasGeneratedBy ECO_0000203 NP925124.RA5DOqe0CqxtOpVX-kTRLxpZ1OhkO3miaE4JErmqx2oiY130_provenance.